Skip to main content
. 2022 Mar 31;15(1):34–41. doi: 10.4103/jhrs.jhrs_147_21

Table 2.

Comparison of insulin resistance, hyperinsulinaemia and hyperhomocysteinaemia in relation to different body mass index categories

Insulin resistance (HOMA-IR >2.5)

Weight category Overall Cases Controls Statistical significance




Total IR (%) Total IR (%) Total IR (%) χ2-test (cases vs. controls)
Normal 19 2 (10.5) 9 2 (22.2) 10 0 χ2=2.484; P=0.115
Overweight 22 6 (27.3) 10 5 (50.0) 12 1 (8.3) χ2=4.774; P=0.029
Obese 29 25 (86.2) 16 16 (100) 13 9 (69.2) χ2=5.711; P=0.017
Inter-BMI category statistical significance χ2=31.47; P<0.001 χ2=17.0; P<0.001 χ2=16.939; P<0.001

Hyperinsulinaemia

Weight category Overall Cases Controls Statistical significance




Total Hyper insulin Total Hyper insulin Total Hyper insulin Cases versus controls (Student’s t-test)

Normal 19 0 9 0 10 0 -
Overweight 22 0 10 0 12 0 -
Obese 29 6 (20.7%) 16 4 (25.0%) 13 2 (15.4%) χ2=0.404; P=0.525
Inter-BMI category statistical significance χ2=9.278; P=0.010 χ2=5.363; P=0.068 χ2=3.590; P=0.166

Hyperhomocysteinaemia

Weight category Overall Cases Controls Cases versus controls



Total Hyper HCy (%) Total Hyper HCy (%) Total Hyper HCy (%)

Normal 19 2 (10.5) 9 1 (11.1) 10 1 (10.0) χ2=0.006; P=0.937
Overweight 22 10 (45.5) 10 7 (70.0) 12 3 (25.0) χ2=4.455; P=0.035
Obese 29 17 (58.6) 16 14 (87.5) 13 3 (23.1) χ2=12.272; P<0.001
Inter-BMI category statistical significance χ2=11.157; P=0.004 χ2=14.702; P=0.001 χ2=0.889; P=0.641

BMI=Body mass index, HOMA-IR=Homoeostatic assessment of insulin resistance, IR=Insulin resistance